10-K Filing

SWK Holdings Corp CIK: 1089907 FY 2024

Filing Information

Form Type	10-K
Accession Number	`0001628280-25-013989`
Period End Date	20241231
Filing Date	20250320
Fiscal Year	2024
Fiscal Period	FY
XBRL Instance	swkh-20241231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 166 Income Statement 104 Cash Flow Statement 172 Stockholders Equity 34

Balance Sheet 166 line items

Line Item	Tag	Value	Unit	Period
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.85M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.85M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Interest, accounts receivable, and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Interest, accounts receivable, and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Interest, accounts receivable, and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Interest, accounts receivable, and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Assets held for sale, net (Note 7)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale, net (Note 7)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Assets held for sale, net (Note 7)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Assets held for sale, net (Note 7)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $11,249 and $13,901 as of December 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetNoncurrent`	$274.50M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $11,249 and $13,901 as of December 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetNoncurrent`	$274.50M	USD	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $11,249 and $13,901 as of December 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $11,249 and $13,901 as of December 31, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$48.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$48.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.22M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.22M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.99M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.99M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Liabilities held for sale (Note 7)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Liabilities held for sale (Note 7)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Liabilities held for sale (Note 7)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale (Note 7)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$9.00K	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$9.00K	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	-	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	-	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time

Income Statement 104 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$40.79M	USD	Annual
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$40.79M	USD	Annual
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$36.35M	USD	Annual
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$36.35M	USD	Annual
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.62M	USD	Annual
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.62M	USD	Annual
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.20M	USD	Annual
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.20M	USD	Annual
Other	`OtherIncome`	$584.00K	USD	Annual
Other	`OtherIncome`	$584.00K	USD	Annual
Other	`OtherIncome`	$212.00K	USD	Annual
Other	`OtherIncome`	$212.00K	USD	Annual
Total revenues	`Revenues`	$37.76M	USD	Annual
Total revenues	`Revenues`	$37.76M	USD	Annual
Total revenues	`Revenues`	$44.99M	USD	Annual
Total revenues	`Revenues`	$44.99M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$12.76M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$12.76M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$1.91M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$1.91M	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$5.77M	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$5.77M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	$8.40M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	$8.40M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	Annual
Interest expense	`InterestExpenseOperating`	$1.85M	USD	Annual
Interest expense	`InterestExpenseOperating`	$1.85M	USD	Annual
Interest expense	`InterestExpenseOperating`	$4.68M	USD	Annual
Interest expense	`InterestExpenseOperating`	$4.68M	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.20M	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.20M	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$3.44M	USD	Annual
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$3.44M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$-4.90M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$-4.90M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$-6.30M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$-6.30M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.58M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.58M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.40M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.40M	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$11.23M	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$11.23M	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$11.49M	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$11.49M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$11.59M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$11.59M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$14.65M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$14.65M	USD	Annual
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-55.00K	USD	Annual
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-55.00K	USD	Annual
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$2.41M	USD	Annual
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$2.41M	USD	Annual
Net gain (loss) on exercise and cancellation of warrants	`FairValueOfCommonStockReceivedUponExerciseOfWarrant`	$-799.00K	USD	Annual
Net gain (loss) on exercise and cancellation of warrants	`FairValueOfCommonStockReceivedUponExerciseOfWarrant`	$-799.00K	USD	Annual
Net gain (loss) on exercise and cancellation of warrants	`FairValueOfCommonStockReceivedUponExerciseOfWarrant`	$445.00K	USD	Annual
Net gain (loss) on exercise and cancellation of warrants	`FairValueOfCommonStockReceivedUponExerciseOfWarrant`	$445.00K	USD	Annual
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-266.00K	USD	Annual
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-266.00K	USD	Annual
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	-	USD	Annual
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	-	USD	Annual
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	Annual
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	Annual
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.06M	USD	Annual
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.06M	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	Annual
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$817.00K	USD	Annual
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$817.00K	USD	Annual
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$641.00K	USD	Annual
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$641.00K	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$14.61M	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$14.61M	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$18.37M	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$18.37M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$4.88M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$4.88M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.27M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.27M	USD	Annual
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.09	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.09	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.26	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.26	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.08	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.08	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.25	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.25	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.37M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.37M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.65M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.65M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.45M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.45M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.70M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.70M	shares	Annual

Cash Flow Statement 172 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$12.76M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$12.76M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$1.91M	USD	Annual
Provision for credit losses	`ProvisionForOtherCreditLosses`	$1.91M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	$8.40M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	$8.40M	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	Annual
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$5.77M	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$5.77M	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	Annual
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	Annual
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$333.00K	USD	Annual
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$333.00K	USD	Annual
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$415.00K	USD	Annual
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$415.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.05M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.05M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$493.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$493.00K	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$4.81M	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$4.81M	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$-1.29M	USD	Annual
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$-1.29M	USD	Annual
Unrealized net (gain) loss on warrants	`FairValueAdjustmentOfWarrants`	$55.00K	USD	Annual
Unrealized net (gain) loss on warrants	`FairValueAdjustmentOfWarrants`	$55.00K	USD	Annual
Unrealized net (gain) loss on warrants	`FairValueAdjustmentOfWarrants`	$-2.41M	USD	Annual
Unrealized net (gain) loss on warrants	`FairValueAdjustmentOfWarrants`	$-2.41M	USD	Annual
Net (gain) loss on exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$799.00K	USD	Annual
Net (gain) loss on exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$799.00K	USD	Annual
Net (gain) loss on exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$-445.00K	USD	Annual
Net (gain) loss on exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$-445.00K	USD	Annual
Net loss on marketable investments	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Net loss on marketable investments	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Net loss on marketable investments	`GainLossOnDispositionOfAssets1`	$-266.00K	USD	Annual
Net loss on marketable investments	`GainLossOnDispositionOfAssets1`	$-266.00K	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-6.30M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-6.30M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-4.90M	USD	Annual
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-4.90M	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	Annual
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	Annual
Foreign currency transaction gain	`ForeignCurrencyTransactionGainBeforeTax`	$1.41M	USD	Annual
Foreign currency transaction gain	`ForeignCurrencyTransactionGainBeforeTax`	$1.41M	USD	Annual
Foreign currency transaction gain	`ForeignCurrencyTransactionGainBeforeTax`	$1.88M	USD	Annual
Foreign currency transaction gain	`ForeignCurrencyTransactionGainBeforeTax`	$1.88M	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$3.83M	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$3.83M	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$3.92M	USD	Annual
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$3.92M	USD	Annual
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$2.81M	USD	Annual
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$2.81M	USD	Annual
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$1.83M	USD	Annual
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$1.83M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$509.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$509.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$944.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$944.00K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.58M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.58M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.40M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.40M	USD	Annual
Interest, accounts receivable and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.64M	USD	Annual
Interest, accounts receivable and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.64M	USD	Annual
Interest, accounts receivable and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.06M	USD	Annual
Interest, accounts receivable and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.06M	USD	Annual
Derivative assets and liabilities, net	`IncreaseDecreaseInDerivativeAssetsAndLiabilities`	$-1.23M	USD	Annual
Derivative assets and liabilities, net	`IncreaseDecreaseInDerivativeAssetsAndLiabilities`	$-1.23M	USD	Annual
Derivative assets and liabilities, net	`IncreaseDecreaseInDerivativeAssetsAndLiabilities`	$-1.06M	USD	Annual
Derivative assets and liabilities, net	`IncreaseDecreaseInDerivativeAssetsAndLiabilities`	$-1.06M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-199.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-199.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$787.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$787.00K	USD	Annual
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.33M	USD	Annual
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.33M	USD	Annual
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$371.00K	USD	Annual
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$371.00K	USD	Annual
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.49M	USD	Annual
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.49M	USD	Annual
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$26.00K	USD	Annual
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$26.00K	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$23.05M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$23.05M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.89M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.89M	USD	Annual
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$13.94M	USD	Annual
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$13.94M	USD	Annual
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	Annual
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	Annual
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$574.00K	USD	Annual
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$574.00K	USD	Annual
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	Annual
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$74.12M	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$74.12M	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$63.71M	USD	Annual
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$63.71M	USD	Annual
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$11.70M	USD	Annual
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$11.70M	USD	Annual
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$53.11M	USD	Annual
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$53.11M	USD	Annual
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$28.00K	USD	Annual
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$28.00K	USD	Annual
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$27.00K	USD	Annual
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$27.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$138.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$138.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$496.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$496.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.13M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.13M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-48.95M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-48.95M	USD	Annual
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	Annual
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	Annual
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	Annual
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	Annual
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$9.90M	USD	Annual
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$9.90M	USD	Annual
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.12M	USD	Annual
Net (payments on) proceeds from credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.12M	USD	Annual
Payments for financing costs	`PaymentsOfFinancingCosts`	$50.00K	USD	Annual
Payments for financing costs	`PaymentsOfFinancingCosts`	$50.00K	USD	Annual
Payments for financing costs	`PaymentsOfFinancingCosts`	$3.41M	USD	Annual
Payments for financing costs	`PaymentsOfFinancingCosts`	$3.41M	USD	Annual
Proceeds from senior unsecured notes	`ProceedsFromUnsecuredNotesPayable`	-	USD	Annual
Proceeds from senior unsecured notes	`ProceedsFromUnsecuredNotesPayable`	-	USD	Annual
Proceeds from senior unsecured notes	`ProceedsFromUnsecuredNotesPayable`	$32.97M	USD	Annual
Proceeds from senior unsecured notes	`ProceedsFromUnsecuredNotesPayable`	$32.97M	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$6.33M	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$6.33M	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$6.01M	USD	Annual
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$6.01M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-12.22M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-12.22M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$33.14M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$33.14M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$691.00K	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$691.00K	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-920.00K	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-920.00K	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	Annual
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	Annual
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	Annual
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	$1.35M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$1.35M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.08M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.08M	USD	Annual
Fair value of warrants received with finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$1.36M	USD	Annual
Fair value of warrants received with finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$1.36M	USD	Annual
Fair value of warrants received with finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$1.24M	USD	Annual
Fair value of warrants received with finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$1.24M	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$509.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$509.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$944.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$944.00K	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$6.33M	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$6.33M	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$6.01M	USD	Annual
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$6.01M	USD	Annual
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	Annual
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	Annual
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$13.49M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Net income	`NetIncomeLoss`	$15.89M	USD	Annual
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.